UPDATE: Jefferies Raises PT on Health Management Associates on Continued Positive Outlook

In a report published Wednesday, Jefferies analyst Brian Tanquilut reiterated a Buy rating on Health Management Associates (NYSE: HMA), and raised the price target from $14.50 to $20.00.

In the report, Jefferies noted, “We continue to have a positive view on HMA shares despite the stock's recent run given our belief that the strategic review being undertaken by mgmt will most likely result in the eventual sale of the company. Consistent with yesterday's media reports, we believe hospital providers CYH and HCA are both interested in evaluating an acquisition of HMA. At current levels, we believe HMA's risk-reward is compelling. Raising PT to $20.”

Health Management Associates closed on Tuesday at $16.75.